To include your compound in the COVID-19 Resource Center, submit it here.
Syntimmune Inc. (Waltham, Mass.) reported data from a Phase Ia trial in 31 healthy volunteers showing
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury